Our results show that Multicilin in combination with an activated form of E2f4 can act in MEFs to selectively upregulate gene expression associated with MCC differentiation, while leaving largely untouched the expression of genes involved in other aspects of cell cycle progression. Here, E2F4 is linked to Merkel cell skin cancer.